Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder — recommendations from ECTRIMS and the EBMT
Imperial College London · Azienda Ospedaliero-Universitaria Careggi · +66 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
43
total citations
- FWCI
- 47.41
- Percentile
- 100%
- References
- 167
Citations per year
Authors
45Topics & keywords
Topics
Keywords
- Medicine
- Neuromyelitis optica
- Spectrum disorder
- Multiple sclerosis
- Transplantation
- Stem cell
- Hematopoietic stem cell transplantation
- Haematopoiesis
UN Sustainable Development Goals
- Partnerships for the goals
No related works found for this paper.
Funding
- AAmgen
- BSBristol-Myers Squibb
- PPfizer
- AAstraZeneca
- SSanofi
- BBiogen
- TPTeva Pharmaceutical Industries
- APAlexion Pharmaceuticals
- CCelgene
- UBUniversität Basel
- ECEuropean Committee for Treatment and Research in Multiple Sclerosis
- NRNational Research Foundation
- MMedac
- MPMedDay Pharmaceuticals
- ESEMD Serono
- MRMedical Research CouncilAward: MR/T024437/1
- CCilag